Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Balloon Valvuloplasty Device Market Expected to Grow Between 2025 And 2029?

In recent years, there has been a marked increase in the market size of the balloon valvuloplasty device. The predicted growth is from $2.44 billion in 2024 to approximately $2.57 billion in 2025, representing a compound annual growth rate (CAGR) of 5.3%. The surge in growth during the historic period is attributed to a number of factors, including increased healthcare spending, expanded healthcare infrastructure, enhanced awareness and diagnostic capacities, a preference for outpatient environments, the rise of telemedicine which has improved accessibility, and a focus on bettering the quality of life for patients.

The market for balloon valvuloplasty devices is projected to experience significant growth in the upcoming years, reaching $3.2 billion in 2029 with a compound annual growth rate (CAGR) of 5.6%. This robust growth predicted over the forecast period can be tied back to rising instances of heart valve ailments in older populations globally, heightened uptake of less intrusive treatments for heart valve issues, accelerated sanctioning and clearances for innovative balloon valvuloplasty devices, and a focus on cost-effective healthcare solutions. Key trends during the forecast period include the application of improved imaging techniques for accurate diagnosis, the use of personalized medicine strategies, increased investment in research and development, the expansion of regenerative methods in managing cardiovascular disease, and the incorporation of digital health technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

What Are the Core Market Drivers Propelling Growth in the Balloon Valvuloplasty Device Industry?

The balloon valvuloplasty device market is expected to experience significant growth due to the increasing preference for minimally invasive procedures. These types of procedures involve performing medical techniques via small incisions or natural body openings, resulting in less trauma and leading to quicker recovery compared to conventional surgeries. The appeal of minimally invasive procedures lies in their shorter recovery periods, fewer risks of complications, and less post-operative pain compared to traditional surgeries. In the context of minimally invasive surgical procedures, balloon valvuloplasty devices are utilized to broaden narrowed heart valves, enhance blood flow, and alleviate symptoms. For example, in January 2024, Intuitive Surgical Inc., a US-based corporation that manufactures robotic products, announced that it had installed 415 da Vinci surgical systems (robotic surgical systems that facilitate a minimally invasive surgical procedure) in the fourth quarter of 2023, which is a 12% rise compared to 2022. So, the increasing preference for minimally invasive procedures is fueling the expansion of the balloon valvuloplasty device market.

How Is the Balloon Valvuloplasty Device Market Segmented?

The balloon valvuloplasty devicemarket covered in this report is segmented –

1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon

2) By Age Group: Pediatric, Adult

3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons

2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon

3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons

4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons

5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp

Which Regions Are Driving the Next Phase of the Balloon Valvuloplasty Device Market Growth?

North America was the largest region in the balloon valvuloplasty device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Balloon Valvuloplasty Device Industry?

Leading firms active in the balloon valvuloplasty device market are zeroing in on the development of cutting-edge products such as Pacing Guidewires in a bid to stay ahead of competition. A pacing guidewire is a specific type of wire utilized to achieve temporary cardiac pacing during operations, ensuring a steady heart rhythm whilst the balloon catheter is in the process of insertion and inflation to widen the constricted valve. One example is the instance in June 2023 when Teleflex Incorporated, an American medical device company, secured approval from the Food and Drug Administration (FDA) for their Wattson Temporary Pacing Guidewire. This innovative device is tailored for use in procedures like transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV). The Wattson Temporary Pacing Guidewire provides dual functionality by supporting both valve delivery and ventricular bipolar pacing during these structural heart operations. It’s uniquely flexible distal pigtail shape, coupled with multiple electrodes and bipolar design, are all engineered to minimize the probability of ventricular perforation while simultaneously providing trustworthy electrical capture during accelerated pacing.

View the full report here:

https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

How Is the Balloon Valvuloplasty Device Market Defined and What Are Its Core Parameters?

A balloon valvuloplasty device is a medical instrument used to treat heart valve stenosis by inserting a balloon into the narrowed valve and inflating it to widen the opening, improving blood flow. This non-surgical procedure is minimally invasive and aims to relieve symptoms such as chest pain and shortness of breath, enhancing cardiac function and patient quality of life.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17090

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model